Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 619-636-0 | CAS number: 125971-57-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1997-03-18 to 1999-04-09
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD Guideline study under GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 999
- Report date:
- 1999
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: 92/69/EWG, B.12 (Mikrokerntest); OECD 474
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Details on test material:
- - Name of test material (as cited in study report): PD 132408
- Substance type: white powder
- Physical state: solid
- Storage condition of test material: Roomtemperature in the dark
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River UK Limited, Margate, Kent, England
- Weight on despatch: males weighed between 24 and 28 grams, females weighed between 18 and 22 grams
- Assigned to test groups randomly: yes
- Diet: food and water ad libitum
- Acclimation period: min 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C
- Humidity (%): 50%
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil (Diss Office Line, Batch # F8048 for PD 132408
water for positve control Mitomycin C - Details on exposure:
- All animals in all groups were dosed with the standard volume of 20 mL/kg.
- Duration of treatment / exposure:
- Single treatment
- Frequency of treatment:
- Single treatment
- Post exposure period:
- 24 hours for five animals in all sex/dose/substance groups
48 hours for five animals of both sexes in the control and in the high dose group (2000 mg/kg)
- No. of animals per sex per dose:
- Male: 0 mg/kg; No. of animals: 5; Sacrifice time: 24 hours
Male: 500 mg/kg; No. of animals: 5; Sacrifice time: 24 hours
Male: 1000 mg/kg; No. of animals: 5; Sacrifice time: 24 hours
Male: 2000 mg/kg; No. of animals: 5; Sacrifice time: 24 hours
Male: 0 mg/kg; No. of animals: 5; Sacrifice time: 48 hours
Male: 2000 mg/kg; No. of animals: 5; Sacrifice time: 48 hours
Female: 0 mg/kg; No. of animals: 5; Sacrifice times: 24 hours
Female: 500 mg/kg; No. of animals: 5; Sacrifice times: 24 hours
Female: 1000 mg/kg; No. of animals: 5; Sacrifice times: 24 hours
Female: 2000 mg/kg; No. of animals: 5; Sacrifice times: 24 hours
Female: 0 mg/kg; No. of animals: 5; Sacrifice times: 48 hours
Female: 2000 mg/kg; No. of animals: 5; Sacrifice times: 48 hours - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- five animals of both sexes were treatet with mitomycin c (12 mg/kg bodyweight)
Examinations
- Tissues and cell types examined:
- immature erythrocytes from bone marrow of both femurs
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
Dose selection was based on a preliminary toxicity test with each two animals of both sexes in four dose groups ( 250, 500, 1000, 2000 mg/kg bodyweight)
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
see above
DETAILS OF SLIDE PREPARATION:
The femurs were cleared from tissue and the proximal epiphysis removed from each bone. The bone marro of both femurs from each animal was flushed out and poolded in a total volume of 2 mL of prefiltered foetal calf serum using a 2 mL disposable syringe fitted with a 21 gauge needle. The cells were sedimented by centrifugation, the supernatant was discarded and the cells were resuspended in a small volume of fresh serum. A small drop of the cell suspension was transferred to a glass microscope slide and a smear was prepared in the conventional manner (Schmid 1976) At least three smears were made from each animal. The prepared smears were fixed in methanol (>10 min). After air dryining the smears were stained for 10 minutes in 10% Giemsa prepared by 1:9 dilution of Gurrs improved R66 Giemsa (BDH) with purified water. Following rinsing in purified water adn differentiation in buffered purified water, the smears were air-dried and mounted with coverslips using DPX.
METHOD OF ANALYSIS:
OTHER: - Evaluation criteria:
- The stained smears were examined (under code) by light microscopy to determine the incidence of micronucleated cells per 2000 immature erythrocytes per animal. Usually only one smear per animal was examined. The remaining smears were held temporarily in case of technical problems with the first smear.
A positive response is normally indicated vy a statistically significant dose-related increase in the incidence of micronucleated immature erythrocytes for the treatment group compared with the concurrent control group (p<0.01). Furthermore individual and /or group mean values should exceed the laboratory historical control range.
Bone marrow cell toxicity is normally indicated by a substantial statistically significant dose-related decrease in the proportion of immature erythrocytes (p<0.01) This decrease would normally be evident at the 48 houzr sampling time. - Statistics:
- One-sided p-values by permutation; Linear by Linear Association test for trend in a step-down fashion if significance is detected; for individual inter-group comparisons straight forward permutation test.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- No statistically significant increases in the frequency of micronucleated immature erythrocytes and no substantial decreases in the proportion of immature erythrocytes were observed in mice treated with PD 132408 and killed 24 or 48 hours later, compared to vehicle control values (p>0.01 in each case).
The test substance did not cause any substantial increases in the incidence of micronucleated mature erythrocytes at either sampling time.
Slight signs of toxicity were observed in the highest dose group ( 2000 mg/kg): Underactivity, Fasiculations
The positive control compound, mitomycin C, produced large, highly significant (p<0.001) increases in the frequency of micronucleated immature erythocytes.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
It is concluded that PD 132 408 did not show any evidence of causing chromosome damage or bone marrow cell toxicity when administered orally by intragestic gavage. - Executive summary:
The substance PD 132408 was examined in vivo for clastogenic effects in bone marrow cells of mice. There was no significant induction of micronucleated immature erythrocytes after treatment by ingastric gavage.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.